Cargando…

A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK

Severe combined immunodeficiency (SCID) can be detected through newborn bloodspot screening. In the UK, the National Screening Committee (NSC) requires screening programmes to be cost-effective at standard UK thresholds. To assess the cost-effectiveness of SCID screening for the NSC, a decision-tree...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bessey, Alice, Chilcott, James, Leaviss, Joanna, de la Cruz, Carmen, Wong, Ruth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510246/ https://www.ncbi.nlm.nih.gov/pubmed/33072987 http://dx.doi.org/10.3390/ijns5030028

Ejemplares similares

Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme
por: Bessey, Alice, et al.
Publicado: (2018)

The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism
por: Bessey, Alice, et al.
Publicado: (2020)

Economic Evaluation of Newborn Screening for Severe Combined Immunodeficiency
por: Shih, Sophy T. F., et al.
Publicado: (2022)

Universal Newborn Screening for Severe Combined Immunodeficiency (SCID)
por: van der Burg, Mirjam, et al.
Publicado: (2019)

A Case of Severe Combined Immunodeficiency Missed by Newborn Screening
por: Kitcharoensakkul, Maleewan, et al.
Publicado: (2021)

Modelling the Cost-Effectiveness and Budget Impact of a Newborn Screening Program for Spinal Muscular Atrophy and Severe Combined Immunodeficiency
por: Shih, Sophy T. F., et al.
Publicado: (2022)

A Call to Include Severe Combined Immunodeficiency in Newborn Screening Program
por: Somech, Raz, et al.
Publicado: (2014)

Introducing Newborn Screening for Severe Combined Immunodeficiency—The New Zealand Experience
por: Heather, Natasha, et al.
Publicado: (2022)

Recommendations for uniform definitions used in newborn screening for severe combined immunodeficiency
por: Blom, Maartje, et al.
Publicado: (2022)

Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening Program
por: Blom, Maartje, et al.
Publicado: (2018)

Newborn Screening for Severe Combined Immunodeficiency in the US: Current Status and Approach to Management
por: Dorsey, Morna, et al.
Publicado: (2017)

Positive Newborn Screening for Severe Combined Immunodeficiency: What Should the Pediatrician Do?
por: Mongkonsritragoon, Wimwipa, et al.
Publicado: (2023)

NEWBORN SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCIES USING TRECS AND KRECS: SECOND PILOT STUDY IN BRAZIL
por: Kanegae, Marilia Pyles P., et al.
Publicado: (2017)

TREC Based Newborn Screening for Severe Combined Immunodeficiency Disease: A Systematic Review
por: van der Spek, Jet, et al.
Publicado: (2015)

First Year of Israeli Newborn Screening for Severe Combined Immunodeficiency—Clinical Achievements and Insights
por: Rechavi, Erez, et al.
Publicado: (2017)

A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening
por: Al Sukaiti, Nashat, et al.
Publicado: (2021)

Newborn Screening for Severe Combined Immunodeficiency: Do Preterm Infants Require Special Consideration?
por: Atkins, Anne E., et al.
Publicado: (2021)

Uncertainties experienced by parents of children diagnosed with severe combined immunodeficiency through newborn screening
por: Raspa, Melissa, et al.
Publicado: (2023)

Screening for severe combined immunodeficiency in neonates
por: Kelly, Brian T, et al.
Publicado: (2013)

Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening
por: de Pagter, Anne P. J., et al.
Publicado: (2015)

Development of a Population-Based Newborn Screening Method for Severe Combined Immunodeficiency in Manitoba, Canada
por: Thompson, J. Robert, et al.
Publicado: (2018)

Retrospective TREC testing of newborns with Severe Combined Immunodeficiency and other primary immunodeficiency diseases
por: Jilkina, O., et al.
Publicado: (2014)

A Practical Approach to Newborn Screening for Severe Combined Immunodeficiency Using the T Cell Receptor Excision Circle Assay
por: Thakar, Monica S., et al.
Publicado: (2017)

Newborn Screening for Severe Combined Immunodeficiency Using the Multiple of the Median Values of T-Cell Receptor Excision Circles
por: Cogley, Michael F., et al.
Publicado: (2021)

IN TIME: THE VALUE AND GLOBAL IMPLICATIONSOF NEWBORN SCREENING FORSEVERE COMBINED IMMUNODEFICIENCY
por: Meehan, Cristina, et al.
Publicado: (2018)

First Universal Newborn Screening Program for Severe Combined Immunodeficiency in Europe. Two-Years' Experience in Catalonia (Spain)
por: Argudo-Ramírez, Ana, et al.
Publicado: (2019)

Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined Immunodeficiency
por: Strand, Janne, et al.
Publicado: (2020)

Diagnostic accuracy of conventional oral examination for detecting oral cavity cancer and potentially malignant disorders in patients with clinically evident oral lesions: Systematic review and meta‐analysis
por: Essat, Munira, et al.
Publicado: (2022)

Implementation of Universal Newborn Screening for Severe Combined Immunodeficiency in Singapore While Continuing Routine Bacille-Calmette-Guerin Vaccination Given at Birth
por: Chan, Su-Wan Bianca, et al.
Publicado: (2022)

Newborn screening for severe combined immunodeficiency: The results of the first pilot TREC and KREC study in Ukraine with involving of 10,350 neonates
por: Boyarchuk, Oksana, et al.
Publicado: (2022)

Case Report: Zellweger Syndrome and Humoral Immunodeficiency: The Relevance of Newborn Screening for Primary Immunodeficiency
por: Fazi, C., et al.
Publicado: (2022)

Immunological Findings and Clinical Outcomes of Infants With Positive Newborn Screening for Severe Combined Immunodeficiency From a Tertiary Care Center in the U.S.
por: Mantravadi, Vasudha, et al.
Publicado: (2021)

Second Tier Testing to Reduce the Number of Non-actionable Secondary Findings and False-Positive Referrals in Newborn Screening for Severe Combined Immunodeficiency
por: Blom, Maartje, et al.
Publicado: (2021)

Modern diagnostic capabilities of neonatal screening for primary immunodeficiencies in newborns
por: Khalturina, Evgenia Olegovna, et al.
Publicado: (2021)

Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden—a 2-Year Pilot TREC and KREC Screening Study
por: Barbaro, Michela, et al.
Publicado: (2016)

Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England
por: Weidlich, Diana, et al.
Publicado: (2023)

Follow-Up for an Abnormal Newborn Screen for Severe Combined Immunodeficiencies (NBS SCID): A Clinical Immunology Society (CIS) Survey of Current Practices
por: Knight, Vijaya, et al.
Publicado: (2020)

Identification of 22q11.2 deletion syndrome via newborn screening for severe combined immunodeficiency. Two years’ experience in Catalonia (Spain)
por: Martin‐Nalda, Andrea, et al.
Publicado: (2019)

The Landscape of Severe Combined Immunodeficiency Newborn Screening in the United States in 2020: A Review of Screening Methodologies and Targets, Communication Pathways, and Long-Term Follow-Up Practices
por: Sheller, Ruthanne, et al.
Publicado: (2020)

Study Design for an Evaluation of Newborn Screening for SCID in the UK
por: Elliman, David
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_45g493hu4quk79k7trjb90pp07